Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV003195083 | SCV003891725 | uncertain significance | Inborn genetic diseases | 2023-02-14 | criteria provided, single submitter | clinical testing | The c.3047G>A (p.G1016E) alteration is located in exon 19 (coding exon 17) of the SETD5 gene. This alteration results from a G to A substitution at nucleotide position 3047, causing the glycine (G) at amino acid position 1016 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |